NCT07388355 A Usability Study of a Multi-channel ECG Monitoring Device
| NCT ID | NCT07388355 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wearlinq |
| Condition | Healthy Adult Participants |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-07-06 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2026-07-06 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.
Eligibility Criteria
Inclusion Criteria: * Adult \>18 years old and able to consent * Capable of using a smartphone app * Willing to shave patch area if needed Exclusion Criteria: * Planning to undergo an MRI during the study period * Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results * Presence of pacemaker, ICD or other implanted electronic devices * Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum) * Pregnant or intending to become pregnant during the course of the study
Contact & Investigator
Chris Daniel
STUDY DIRECTOR
WearLinq, Inc.
Frequently Asked Questions
Who can join the NCT07388355 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy Adult Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07388355 currently recruiting?
Yes, NCT07388355 is actively recruiting participants. Contact the research team at abrown@abioclinical.com for enrollment information.
Where is the NCT07388355 trial being conducted?
This trial is being conducted at New London, United States.
Who is sponsoring the NCT07388355 clinical trial?
NCT07388355 is sponsored by Wearlinq. The principal investigator is Chris Daniel at WearLinq, Inc.. The trial plans to enroll 500 participants.